| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury
|
Cragg, Jacquelyn J.
|
|
2019
|
16 |
3 |
p. 858-867
|
article
|
| 2 |
A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury
|
Cragg, Jacquelyn J.
|
|
|
16 |
3 |
p. 858-867
|
article
|
| 3 |
A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury
|
Cragg, Jacquelyn J.
|
|
|
16 |
3 |
p. 858-867
|
article
|
| 4 |
ASENT 2019 Abstracts
|
|
|
2019
|
16 |
3 |
p. 912-919
|
article
|
| 5 |
ASENT 2019 Abstracts
|
|
|
|
16 |
3 |
p. 912-919
|
article
|
| 6 |
ASENT 2019 Abstracts
|
|
|
|
16 |
3 |
p. 912-919
|
article
|
| 7 |
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
|
Lorefice, Lorena
|
|
2019
|
16 |
3 |
p. 797-807
|
article
|
| 8 |
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
|
Lorefice, Lorena
|
|
|
16 |
3 |
p. 797-807
|
article
|
| 9 |
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
|
Lorefice, Lorena
|
|
|
16 |
3 |
p. 797-807
|
article
|
| 10 |
Autoimmune Epilepsy
|
Husari, Khalil S.
|
|
2019
|
16 |
3 |
p. 685-702
|
article
|
| 11 |
Autoimmune Epilepsy
|
Husari, Khalil S.
|
|
|
16 |
3 |
p. 685-702
|
article
|
| 12 |
Autoimmune Epilepsy
|
Husari, Khalil S.
|
|
|
16 |
3 |
p. 685-702
|
article
|
| 13 |
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation
|
Villoslada, Pablo
|
|
2019
|
16 |
3 |
p. 808-827
|
article
|
| 14 |
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation
|
Villoslada, Pablo
|
|
|
16 |
3 |
p. 808-827
|
article
|
| 15 |
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation
|
Villoslada, Pablo
|
|
|
16 |
3 |
p. 808-827
|
article
|
| 16 |
Blood Pressure Control and Protection of the Aging Brain
|
Wahidi, Nasratullah
|
|
2019
|
16 |
3 |
p. 569-579
|
article
|
| 17 |
Blood Pressure Control and Protection of the Aging Brain
|
Wahidi, Nasratullah
|
|
|
16 |
3 |
p. 569-579
|
article
|
| 18 |
Blood Pressure Control and Protection of the Aging Brain
|
Wahidi, Nasratullah
|
|
|
16 |
3 |
p. 569-579
|
article
|
| 19 |
Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?
|
Huang, Ling-Chun
|
|
2019
|
16 |
3 |
p. 703-709
|
article
|
| 20 |
Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?
|
Huang, Ling-Chun
|
|
|
16 |
3 |
p. 703-709
|
article
|
| 21 |
Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?
|
Huang, Ling-Chun
|
|
|
16 |
3 |
p. 703-709
|
article
|
| 22 |
Characterization and Imaging of Lipid-Shelled Microbubbles for Ultrasound-Triggered Release of Xenon
|
Shekhar, Himanshu
|
|
2019
|
16 |
3 |
p. 878-890
|
article
|
| 23 |
Characterization and Imaging of Lipid-Shelled Microbubbles for Ultrasound-Triggered Release of Xenon
|
Shekhar, Himanshu
|
|
|
16 |
3 |
p. 878-890
|
article
|
| 24 |
Characterization and Imaging of Lipid-Shelled Microbubbles for Ultrasound-Triggered Release of Xenon
|
Shekhar, Himanshu
|
|
|
16 |
3 |
p. 878-890
|
article
|
| 25 |
Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases
|
Petrov, Alexey M.
|
|
2019
|
16 |
3 |
p. 635-648
|
article
|
| 26 |
Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases
|
Petrov, Alexey M.
|
|
|
16 |
3 |
p. 635-648
|
article
|
| 27 |
Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases
|
Petrov, Alexey M.
|
|
|
16 |
3 |
p. 635-648
|
article
|
| 28 |
Consequences of Metabolic Disruption in Alzheimer’s Disease Pathology
|
Ryu, J. C.
|
|
2019
|
16 |
3 |
p. 600-610
|
article
|
| 29 |
Consequences of Metabolic Disruption in Alzheimer’s Disease Pathology
|
Ryu, J. C.
|
|
|
16 |
3 |
p. 600-610
|
article
|
| 30 |
Consequences of Metabolic Disruption in Alzheimer's Disease Pathology
|
Ryu, J.C.
|
|
|
16 |
3 |
p. 600-610
|
article
|
| 31 |
Correction to: Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
|
Peng, Wesley
|
|
2019
|
16 |
3 |
p. 920-921
|
article
|
| 32 |
Correction to: Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
|
Peng, Wesley
|
|
|
16 |
3 |
p. 920-921
|
article
|
| 33 |
CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice
|
Petrov, Alexey M.
|
|
2019
|
16 |
3 |
p. 710-724
|
article
|
| 34 |
CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice
|
Petrov, Alexey M.
|
|
|
16 |
3 |
p. 710-724
|
article
|
| 35 |
CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice
|
Petrov, Alexey M.
|
|
|
16 |
3 |
p. 710-724
|
article
|
| 36 |
Differentiation Between Guillain–Barré Syndrome and Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuritis—a Prospective Follow-up Study Using Ultrasound and Neurophysiological Measurements
|
Grimm, Alexander
|
|
2019
|
16 |
3 |
p. 838-847
|
article
|
| 37 |
Differentiation Between Guillain–Barré Syndrome and Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuritis—a Prospective Follow-up Study Using Ultrasound and Neurophysiological Measurements
|
Grimm, Alexander
|
|
|
16 |
3 |
p. 838-847
|
article
|
| 38 |
Differentiation Between Guillain–Barré Syndrome and Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuritis—a Prospective Follow-up Study Using Ultrasound and Neurophysiological Measurements
|
Grimm, Alexander
|
|
|
16 |
3 |
p. 838-847
|
article
|
| 39 |
Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis
|
Zhang, Yan
|
|
2019
|
16 |
3 |
p. 828-837
|
article
|
| 40 |
Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis
|
Zhang, Yan
|
|
|
16 |
3 |
p. 828-837
|
article
|
| 41 |
Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis
|
Zhang, Yan
|
|
|
16 |
3 |
p. 828-837
|
article
|
| 42 |
Exercise for Brain Health: An Investigation into the Underlying Mechanisms Guided by Dose
|
Cabral, Danylo F.
|
|
2019
|
16 |
3 |
p. 580-599
|
article
|
| 43 |
Exercise for Brain Health: An Investigation into the Underlying Mechanisms Guided by Dose
|
Cabral, Danylo F.
|
|
|
16 |
3 |
p. 580-599
|
article
|
| 44 |
Exercise for Brain Health: An Investigation into the Underlying Mechanisms Guided by Dose
|
Cabral, Danylo F.
|
|
|
16 |
3 |
p. 580-599
|
article
|
| 45 |
High-Throughput Profiling of Circulating Antibody Signatures for Stroke Diagnosis Using Small Volumes of Whole Blood
|
O’Connell, Grant C.
|
|
2019
|
16 |
3 |
p. 868-877
|
article
|
| 46 |
High-Throughput Profiling of Circulating Antibody Signatures for Stroke Diagnosis Using Small Volumes of Whole Blood
|
O’Connell, Grant C.
|
|
|
16 |
3 |
p. 868-877
|
article
|
| 47 |
High-Throughput Profiling of Circulating Antibody Signatures for Stroke Diagnosis Using Small Volumes of Whole Blood
|
O'Connell, Grant C.
|
|
|
16 |
3 |
p. 868-877
|
article
|
| 48 |
Increased TRPM4 Activity in Cerebral Artery Myocytes Contributes to Cerebral Blood Flow Reduction After Subarachnoid Hemorrhage in Rats
|
Gong, Yi
|
|
2019
|
16 |
3 |
p. 901-911
|
article
|
| 49 |
Increased TRPM4 Activity in Cerebral Artery Myocytes Contributes to Cerebral Blood Flow Reduction After Subarachnoid Hemorrhage in Rats
|
Gong, Yi
|
|
|
16 |
3 |
p. 901-911
|
article
|
| 50 |
Increased TRPM4 Activity in Cerebral Artery Myocytes Contributes to Cerebral Blood Flow Reduction After Subarachnoid Hemorrhage in Rats
|
Gong, Yi
|
|
|
16 |
3 |
p. 901-911
|
article
|
| 51 |
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats
|
Drews, Henning J.
|
|
2019
|
16 |
3 |
p. 725-740
|
article
|
| 52 |
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats
|
Drews, Henning J.
|
|
|
16 |
3 |
p. 725-740
|
article
|
| 53 |
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats
|
Drews, Henning J.
|
|
|
16 |
3 |
p. 725-740
|
article
|
| 54 |
Long-Term Follow-up in Patients with Spontaneous Intracerebral Hemorrhage Treated With or Without Surgical Intervention: a Large-Scale Retrospective Study
|
Chen, XianXiu
|
|
2019
|
16 |
3 |
p. 891-900
|
article
|
| 55 |
Long-Term Follow-up in Patients with Spontaneous Intracerebral Hemorrhage Treated With or Without Surgical Intervention: a Large-Scale Retrospective Study
|
Chen, XianXiu
|
|
|
16 |
3 |
p. 891-900
|
article
|
| 56 |
Long-Term Follow-up in Patients with Spontaneous Intracerebral Hemorrhage Treated With or Without Surgical Intervention: a Large-Scale Retrospective Study
|
Chen, XianXiu
|
|
|
16 |
3 |
p. 891-900
|
article
|
| 57 |
Molecular Signatures of the Aging Brain: Finding the Links Between Genes and Phenotypes
|
Lupo, Giuseppe
|
|
2019
|
16 |
3 |
p. 543-553
|
article
|
| 58 |
Molecular Signatures of the Aging Brain: Finding the Links Between Genes and Phenotypes
|
Lupo, Giuseppe
|
|
|
16 |
3 |
p. 543-553
|
article
|
| 59 |
Molecular Signatures of the Aging Brain: Finding the Links Between Genes and Phenotypes
|
Lupo, Giuseppe
|
|
|
16 |
3 |
p. 543-553
|
article
|
| 60 |
Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington’s Disease
|
Cabanas, Magali
|
|
2019
|
16 |
3 |
p. 784-796
|
article
|
| 61 |
Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington’s Disease
|
Cabanas, Magali
|
|
|
16 |
3 |
p. 784-796
|
article
|
| 62 |
Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease
|
Cabanas, Magali
|
|
|
16 |
3 |
p. 784-796
|
article
|
| 63 |
Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson’s Disease Mice via Gut Microbiota and Metabolites
|
Zhou, Zhi-Lan
|
|
2019
|
16 |
3 |
p. 741-760
|
article
|
| 64 |
Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson’s Disease Mice via Gut Microbiota and Metabolites
|
Zhou, Zhi-Lan
|
|
|
16 |
3 |
p. 741-760
|
article
|
| 65 |
Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites
|
Zhou, Zhi-Lan
|
|
|
16 |
3 |
p. 741-760
|
article
|
| 66 |
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders
|
Singh, Sandeep Kumar
|
|
2019
|
16 |
3 |
p. 666-674
|
article
|
| 67 |
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders
|
Singh, Sandeep Kumar
|
|
|
16 |
3 |
p. 666-674
|
article
|
| 68 |
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders
|
Singh, Sandeep Kumar
|
|
|
16 |
3 |
p. 666-674
|
article
|
| 69 |
Neurotherapeutics of the Aging Brain: Complexity Meets Complexity
|
Lerner, Alan J.
|
|
2019
|
16 |
3 |
p. 539-542
|
article
|
| 70 |
Neurotherapeutics of the Aging Brain: Complexity Meets Complexity
|
Lerner, Alan J.
|
|
|
16 |
3 |
p. 539-542
|
article
|
| 71 |
PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson’s Disease
|
Luo, Wen Yuan
|
|
2019
|
16 |
3 |
p. 761-783
|
article
|
| 72 |
PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson’s Disease
|
Luo, Wen Yuan
|
|
|
16 |
3 |
p. 761-783
|
article
|
| 73 |
PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson's Disease
|
Luo, Wen Yuan
|
|
|
16 |
3 |
p. 761-783
|
article
|
| 74 |
Plasma-Based Strategies for Therapeutic Modulation of Brain Aging
|
Kheifets, Viktoria
|
|
2019
|
16 |
3 |
p. 675-684
|
article
|
| 75 |
Plasma-Based Strategies for Therapeutic Modulation of Brain Aging
|
Kheifets, Viktoria
|
|
|
16 |
3 |
p. 675-684
|
article
|
| 76 |
Plasma-Based Strategies for Therapeutic Modulation of Brain Aging
|
Kheifets, Viktoria
|
|
|
16 |
3 |
p. 675-684
|
article
|
| 77 |
Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
|
Peng, Wesley
|
|
|
16 |
3 |
p. 611-634
|
article
|
| 78 |
Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
|
Peng, Wesley
|
|
|
16 |
3 |
p. 611-634
|
article
|
| 79 |
Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
|
Peng, Wesley
|
|
|
16 |
3 |
p. 611-634
|
article
|
| 80 |
Sleep as a Therapeutic Target in the Aging Brain
|
Bah, Thierno M.
|
|
2019
|
16 |
3 |
p. 554-568
|
article
|
| 81 |
Sleep as a Therapeutic Target in the Aging Brain
|
Bah, Thierno M.
|
|
|
16 |
3 |
p. 554-568
|
article
|
| 82 |
Sleep as a Therapeutic Target in the Aging Brain
|
Bah, Thierno M.
|
|
|
16 |
3 |
p. 554-568
|
article
|
| 83 |
The Role of Estrogen in Brain and Cognitive Aging
|
Russell, Jason K.
|
|
2019
|
16 |
3 |
p. 649-665
|
article
|
| 84 |
The Role of Estrogen in Brain and Cognitive Aging
|
Russell, Jason K.
|
|
|
16 |
3 |
p. 649-665
|
article
|
| 85 |
The Role of Estrogen in Brain and Cognitive Aging
|
Russell, Jason K.
|
|
|
16 |
3 |
p. 649-665
|
article
|
| 86 |
Treatment Responsiveness in KCNT1-Related Epilepsy
|
Fitzgerald, Mark P.
|
|
2019
|
16 |
3 |
p. 848-857
|
article
|
| 87 |
Treatment Responsiveness in KCNT1-Related Epilepsy
|
Fitzgerald, Mark P.
|
|
|
16 |
3 |
p. 848-857
|
article
|
| 88 |
Treatment Responsiveness in KCNT1-Related Epilepsy
|
Fitzgerald, Mark P.
|
|
|
16 |
3 |
p. 848-857
|
article
|
Journal description